Nivolumab in relapsed refractory Hodgkin Lymphoma

E-session 400 / CME accredited Add to My Agenda

Expert:

Astrid Pavlovsky, expert of session 'Nivolumab in relapsed refractory Hodgkin Lymphoma'

Astrid Pavlovsky
Clinical Research Center - FUNDALEU
Buenos Aires, Argentina

Discussant: Emanuele Zucca
Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

View slides

Enter the recorded session

Share on:

15
Jun 2017
18:15-19:00 CET

Top